Difference between revisions of "Aspirin and dipyridamole (Aggrenox)"
Jump to navigation
Jump to search
m |
m |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
From the FDA label: A combination antiplatelet agent. Each hard gelatin capsule contains 200 mg of [[Dipyridamole (Persantine)|dipyridamole]] in an extended-release form and 25 mg of [[aspirin]], as an immediate-release sugar-coated tablet. | From the FDA label: A combination antiplatelet agent. Each hard gelatin capsule contains 200 mg of [[Dipyridamole (Persantine)|dipyridamole]] in an extended-release form and 25 mg of [[aspirin]], as an immediate-release sugar-coated tablet. | ||
| − | [[Category: | + | ==Also known as== |
| + | *'''Brand name:''' Aggrenox | ||
| + | |||
| + | [[Category:Drugs]] | ||
| + | [[Category:Combination drugs]] | ||
[[Category:Oral medications]] | [[Category:Oral medications]] | ||
| Line 8: | Line 12: | ||
[[Category:Antipyretics]] | [[Category:Antipyretics]] | ||
| − | [[Category: | + | [[Category:FDA approved in 1999]] |
| − | |||
Latest revision as of 22:08, 22 March 2022
From the FDA label: A combination antiplatelet agent. Each hard gelatin capsule contains 200 mg of dipyridamole in an extended-release form and 25 mg of aspirin, as an immediate-release sugar-coated tablet.
Also known as
- Brand name: Aggrenox